Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-11-15 Sale |
2024-11-19 9:20 pm |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
82,910 | $4.9925 | $413,925 | 339,166 (Indirect Direct) |
View |
2023-08-29 Purchase(A) |
2023-08-31 11:26 am |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
881,000 | $0.0187 | $16,475 | 30,272,724 (Indirect Direct) |
View |
2023-08-29 Purchase |
2023-08-29 6:39 pm |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
881,000 | $0.0187 | $16,475 | 43,807,874 (Direct) |
View |
2020-08-07 Purchase(M) |
2020-08-11 2:53 pm |
Emerald Bioscience Inc. | EMBI | DHILLON PUNIT CEO |
1,000,000 | $0.1 | $100,000 | 10,200,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-02-24 Option Award |
2025-02-26 5:43 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
250,000 | $0 | 250,000 (Direct) |
View |
2024-10-28 Option Award |
2024-10-30 8:31 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
650,000 | $0 | 650,000 (Direct) |
View |
2024-08-26 Other |
2024-08-27 5:20 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
15,727 | $0 | 437,803 (Direct) |
View |
2024-02-29 Option Award(A) |
2024-03-04 06:13 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
225,000 | $0 | 522,006 (Direct) |
View |
2024-02-29 Option Award |
2024-03-01 6:24 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
225,000 | $0 | 522,006 (Direct) |
View |
2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
215,856 | $0 | 327,605 (Direct) |
View |
2023-08-23 Acquisition(A) |
2023-08-31 11:26 am |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
9,000 | $0.0118 | 30,272,724 (Direct) |
View |
2023-08-25 Option Award(A) |
2023-08-31 11:26 am |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
22,530,460 | $0 | 30,272,724 (Direct) |
View |
2023-08-28 Acquisition(A) |
2023-08-31 11:26 am |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
110,000 | $0.0171 | 30,272,724 (Direct) |
View |
2023-08-23 Acquisition |
2023-08-29 6:39 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
9,000 | $0.0118 | 43,807,874 (Direct) |
View |
2023-08-25 Option Award |
2023-08-29 6:39 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
22,530,460 | $0 | 43,807,874 (Direct) |
View |
2023-08-28 Acquisition |
2023-08-29 6:39 pm |
N/A N/A |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
110,000 | $0.0171 | 43,807,874 (Direct) |
View |
2022-11-10 Option Award |
2022-11-15 1:41 pm |
N/A 2024-04-03 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
5,302,264 | $0 | 8,302,264 (Direct) |
View |
2022-11-10 Option Award |
2022-11-10 9:54 pm |
N/A 2032-11-10 |
Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director |
250,000 | $0 | 250,000 (Direct) |
View |
2021-12-14 Option Award |
2021-12-16 7:03 pm |
N/A 2031-12-14 |
Skye Bioscience Inc. | SKYE | DHILLON PUNIT Chief Executive Officer |
5,090,000 | $0 | 6,090,000 (Direct) |
View |
2021-09-27 Option Award |
2021-10-01 08:11 am |
N/A 2031-09-26 |
Arch Therapeutics Inc. | ARTH | DHILLON PUNIT Director |
500,000 | $0 | 500,000 (Direct) |
View |
2020-08-07 Option Award |
2020-08-11 2:53 pm |
N/A N/A |
Emerald Bioscience Inc. | EMBI | DHILLON PUNIT CEO |
9,000,000 | $0 | 10,200,000 (Direct) |
View |